Guillermo Montalban-Bravo Selected Research

Leukocytosis (Pleocytosis)

1/2022

Prediction of survival with intensive chemotherapy in acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guillermo Montalban-Bravo Research Topics

Disease

24	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 04/2018
22	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2024 - 05/2017
14	Neoplasms (Cancer) 03/2024 - 01/2017
11	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 03/2024 - 01/2017
5	Leukemia 12/2022 - 01/2021
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2024 - 10/2017
3	Disease Progression 05/2024 - 01/2022
3	Anemia 01/2023 - 01/2018
3	Infections 01/2023 - 01/2022
3	Philadelphia Chromosome 01/2023 - 01/2021
2	Thrombocytopenia (Thrombopenia) 01/2023 - 01/2022
2	Blast Crisis (Blast Phase) 01/2023 - 10/2021
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2023 - 01/2022
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 01/2021
1	Second Primary Neoplasms (Neoplasms, Second) 03/2024
1	Multiple Myeloma 02/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Tremor (Tremors) 01/2023
1	Thrombosis (Thrombus) 01/2023
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2023
1	Pain (Aches) 01/2023
1	Invasive Fungal Infections 10/2022
1	Leukocytosis (Pleocytosis) 01/2022
1	Fever of Unknown Origin 01/2022
1	BCR-ABL Negative Atypical Chronic Myeloid Leukemia (Leukemia, Myeloid, Philadelphia Negative) 01/2021
1	B-Cell Leukemia (Leukemia, B Cell) 01/2019

Drug/Important Bio-Agent (IBA)

19	venetoclaxIBA 03/2024 - 01/2021
7	Azacitidine (5 Azacytidine)FDA Link 01/2023 - 01/2017
4	Decitabine FDA Link 02/2024 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2017
2	DNA (Deoxyribonucleic Acid)IBA 02/2023 - 01/2019
2	blinatumomabIBA 01/2023 - 01/2021
2	Cladribine FDA LinkGeneric 01/2023 - 11/2022
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 11/2022
2	EnzymesIBA 01/2023 - 01/2023
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 01/2022
2	Enhancer of Zeste Homolog 2 ProteinIBA 01/2022 - 01/2019
2	Lenalidomide (CC 5013)FDA Link 01/2019 - 01/2018
1	cedazuridineIBA 02/2024
1	CPX-351IBA 11/2023
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2023
1	Lipase (Acid Lipase)FDA Link 01/2023
1	Alanine Transaminase (SGPT)IBA 01/2023
1	Amylases FDA Link 01/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023
1	ponatinibIBA 01/2023
1	pevonedistatIBA 01/2023
1	enasidenibIBA 01/2023
1	DS-5272IBA 12/2022
1	RNA (Ribonucleic Acid)IBA 12/2022
1	TriazolesIBA 10/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	CreatinineIBA 01/2022
1	trametinibIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 11/2021
1	pembrolizumabIBA 11/2021
1	LigandsIBA 11/2021
1	Codon (Codons)IBA 10/2021
1	Inotuzumab OzogamicinIBA 01/2021
1	Interferon Type IIBA 01/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Core Binding Factors (Core-Binding Factor)IBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2020
1	RNA Helicases (RNA Helicase)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	NucleophosminIBA 01/2019
1	MethyltransferasesIBA 01/2019
1	Janus Kinase 2IBA 01/2019
1	HomoharringtonineIBA 01/2019
1	DioxygenasesIBA 01/2019
1	Amino Acids FDA Link 04/2018
1	alpha-hydroxyglutarateIBA 04/2018
1	SB939 compoundIBA 05/2017

Therapy/Procedure

31	Therapeutics 03/2024 - 05/2017
11	Drug Therapy (Chemotherapy) 05/2024 - 01/2019
2	Immunotherapy 01/2022 - 01/2020
1	Remission Induction 10/2022
1	Salvage Therapy 01/2021